LEADER 01914nas  2200565-a 450 
001 9910143545303321
005 20240413025701.0
011   $a1790-6245
035   $a(CKB)111088195218238
035   $a(CONSER)--2004243376
035   $a(DE-599)ZDB2145919-8
035   $a(EXLCZ)99111088195218238
100   $a20030820a20049999  ---         -
101 0 $aeng
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aCancer genomics & proteomics
210   $aKapandriti, Attiki, Greece $cInternational Institute of Anticancer Research$d[2004]-
215   $a1 online resource
300   $aRefereed/Peer-reviewed
300   $aTitle from cover.
311 08$aPrint version: Cancer genomics & proteomics. 1109-6535 (DLC)  2004243376 (OCoLC)55227675 
517 3 $aCancer genomics and proteomics
531   $aCANCER GENOMICS AND PROTEOMICS
531   $aCANCER GENOMICS PROTEOMICS
531   $aCANCER GENOMICS  PROTEOMICS
531   $aCANCER GENOM PROTEOM
606   $aCancer$xGenetic aspects$vPeriodicals
606   $aCarcinogenesis$xMolecular aspects$vPeriodicals
606   $aNeoplasms$xgenetics
606   $aGenomics
606   $aProteomics
606   $aCancer$xGenetic aspects$2fast$3(OCoLC)fst00845368
606   $aCarcinogenesis$xMolecular aspects$2fast$3(OCoLC)fst00846978
608   $aPeriodical.
608   $aPeriodicals.$2fast
615  0$aCancer$xGenetic aspects
615  0$aCarcinogenesis$xMolecular aspects
615 12$aNeoplasms$xgenetics.
615 22$aGenomics.
615 22$aProteomics.
615  7$aCancer$xGenetic aspects.
615  7$aCarcinogenesis$xMolecular aspects.
712 02$aInternational Institute of Anticancer Research.
906   $aJOURNAL
912   $a9910143545303321
920   $aexl_impl conversion
996   $aCancer genomics & proteomics$92044277
997   $aUNINA